Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Thompson

Showing results (41-50 of 692) with videos related to

Pageof 70
Sort By:
American Journal of Surgery|May 15, 2013
Mitotic rate in melanoma should be recorded as the number of mitoses per mm² (not per high power field): surgeons tell your pathologists!Richard A Scolyer, John F Thompson
Oncotarget|June 13, 2024
When does a melanoma metastasize? Implications for managementJohn F Thompson, Gabrielle J Williams
Genome Biology|February 26, 2011
The properties and applications of single-molecule DNA sequencingJohn F Thompson, Patrice M Milos
Annals of Surgical Oncology|April 14, 2005
Desmoplastic melanoma: a heterogeneous entity in which subclassification as "pure" or "mixed" may have important prognostic significanceRichard A Scolyer, John F Thompson
Electrophoresis|December 5, 2012
Mapping and sequencing DNA using nanopores and nanodetectorsJohn F Thompson, John S Oliver
BMJ Quality & Safety|January 5, 2019
Sentinel lymph node biopsy for in situ melanoma is unlikely in AustraliaRachael L Morton, John F Thompson
Expert Review of Anticancer Therapy|November 10, 2009
Predicting response to IL-2 therapy for metastatic melanomaAlexander D Guminski, John F Thompson
American Journal of Clinical Dermatology|October 5, 2011
Topical diphencyprone immunotherapy for a large primary melanoma on an elderly legDiona L Damian, John F Thompson
ANZ Journal of Surgery|November 14, 2014
Sentinel node biopsy is now part of routine staging in patients with clinically localized melanomaOmgo E Nieweg, John F Thompson
Expert Review of Clinical Pharmacology|November 6, 2019
Managing in-transit melanoma metastases in the new era of effective systemic therapies for melanomaRebecca L Read, John F Thompson
Pageof 70

Showing results (41-50 of 692) with videos related to

Sort By:
Pageof 70
American Journal of Surgery|May 15, 2013
Mitotic rate in melanoma should be recorded as the number of mitoses per mm² (not per high power field): surgeons tell your pathologists!Richard A Scolyer, John F Thompson
Oncotarget|June 13, 2024
When does a melanoma metastasize? Implications for managementJohn F Thompson, Gabrielle J Williams
Genome Biology|February 26, 2011
The properties and applications of single-molecule DNA sequencingJohn F Thompson, Patrice M Milos
Annals of Surgical Oncology|April 14, 2005
Desmoplastic melanoma: a heterogeneous entity in which subclassification as "pure" or "mixed" may have important prognostic significanceRichard A Scolyer, John F Thompson
Electrophoresis|December 5, 2012
Mapping and sequencing DNA using nanopores and nanodetectorsJohn F Thompson, John S Oliver
BMJ Quality & Safety|January 5, 2019
Sentinel lymph node biopsy for in situ melanoma is unlikely in AustraliaRachael L Morton, John F Thompson
Expert Review of Anticancer Therapy|November 10, 2009
Predicting response to IL-2 therapy for metastatic melanomaAlexander D Guminski, John F Thompson
American Journal of Clinical Dermatology|October 5, 2011
Topical diphencyprone immunotherapy for a large primary melanoma on an elderly legDiona L Damian, John F Thompson
ANZ Journal of Surgery|November 14, 2014
Sentinel node biopsy is now part of routine staging in patients with clinically localized melanomaOmgo E Nieweg, John F Thompson
Expert Review of Clinical Pharmacology|November 6, 2019
Managing in-transit melanoma metastases in the new era of effective systemic therapies for melanomaRebecca L Read, John F Thompson
Pageof 70